Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy

Boron neutron capture therapy (BNCT) was clinically approved in 2020 and exhibits remarkable tumour rejection in preclinical and clinical studies. It is binary radiotherapy that may selectively deposit two deadly high-energy particles ((4)He and (7)Li) within a cancer cell. As a radiotherapy induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yaxin, Guo, Zhibin, Fu, Qiang, Shen, Xinyuan, Zhang, Zhongming, Sun, Wenjia, Wang, Jinqiang, Sun, Junliang, Zhang, Zizhu, Liu, Tong, Gu, Zhen, Liu, Zhibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076324/
https://www.ncbi.nlm.nih.gov/pubmed/37019890
http://dx.doi.org/10.1038/s41467-023-37253-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076324/
https://www.ncbi.nlm.nih.gov/pubmed/37019890
http://dx.doi.org/10.1038/s41467-023-37253-x

Ejemplares similares